The role of protein arginine methylation in chemo-resistance

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047813

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

case series:None

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: More than 2 pathologists re-read the pictures together and confirmed the diagnosis as breast cancer.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
methylase CARM1;ERa;Methylated MED12;	—

Countries

America

Contacts

Public ContactBian Xiuwu

Army Medical University

bianxiuwu@263.net+86 23 68754431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026